Tenon Medical, Inc. Common Stock (TNON) Stock Price

TNONStock

$2.70−93.83%52W

Market Cap$7.26M

P/E—

PEG Ratio—

Div yield—

Beta1.44

TNON Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-100.50%

Price vs S&P 500 (4W)-26.29%

VGM Score56.08

Book Value / Share (Quarterly)$5.87

P/TBV (Annual)2.32x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)78.80%

Cash Flow / Share (Quarterly)$-36.52

Price vs S&P 500 (YTD)-103.82%

Gross Margin (TTM)66.81%

Net Profit Margin (TTM)-257.85%

EPS (TTM)$-47.43

10-Day Avg Trading Volume0.25M

EPS Excl Extra (TTM)$-47.43

Revenue Growth (5Y)150.48%

EPS (Annual)$-59.52

ROI (Annual)-249.13%

Gross Margin (Annual)59.79%

Net Profit Margin (5Y Avg)-1683.20%

Cash / Share (Quarterly)$5.07

Revenue Growth QoQ (YoY)126.77%

ROA (Last FY)-116.69%

Revenue Growth TTM (YoY)80.25%

EBITD / Share (TTM)$-43.15

Operating Margin (TTM)-242.70%

Cash Flow / Share (Annual)$-35.54

P/B Ratio3.83x

P/B Ratio (Quarterly)4.33x

Net Income / Employee (Annual)$-482,900

EV / Revenue (TTM)1.87x

Net Interest Coverage (TTM)-110.29x

ROA (TTM)-124.84%

EPS Incl Extra (Annual)$-59.52

Current Ratio (Annual)2.11x

Quick Ratio (Quarterly)0.44x

3-Month Avg Trading Volume4.71M

52-Week Price Return-93.83%

Revenue / Employee (TTM)$204,300

Tangible BV / Share (Quarterly)$4.42

P/S Ratio (Annual)1.84x

Asset Turnover (Annual)0.37x

52-Week High$50.40

Operating Margin (5Y Avg)-1606.71%

EPS Excl Extra (Annual)$-59.52

26-Week Price Return-90.59%

Quick Ratio (Annual)1.70x

13-Week Price Return-61.70%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)0.58x

Enterprise Value$9.91M

Revenue / Share Growth (5Y)249.80%

Asset Turnover (TTM)0.48x

Revenue / Employee (Annual)$151,700

Inventory Turnover (Annual)1.91x

Pretax Margin (Annual)-318.36%

Cash / Share (Annual)$12.12

3-Month Return Std Dev370.16%

Gross Margin (5Y Avg)26.08%

Net Income / Employee (TTM)$-526,800

ROE (Last FY)-249.13%

Net Interest Coverage (Annual)-6.69x

EPS Basic Excl Extra (Annual)$-59.52

Receivables Turnover (TTM)3.91x

Total Debt / Equity (Quarterly)1.84x

EPS Incl Extra (TTM)$-47.43

Receivables Turnover (Annual)3.08x

ROI (TTM)-226.51%

P/S Ratio (TTM)1.37x

Pretax Margin (5Y Avg)-1686.95%

Revenue / Share (Annual)$18.70

Tangible BV / Share (Annual)$14.69

Price vs S&P 500 (52W)-109.36%

Year-to-Date Return-91.89%

5-Day Price Return-9.40%

EPS Normalized (Annual)$-59.52

ROA (5Y Avg)-149.56%

Net Profit Margin (Annual)-318.36%

Month-to-Date Return-33.99%

Cash Flow / Share (TTM)$-13.87

EBITD / Share (Annual)$-59.40

Operating Margin (Annual)-324.34%

EPS Basic Excl Extra (TTM)$-47.43

P/TBV (Quarterly)5.75x

P/B Ratio (Annual)2.10x

Inventory Turnover (TTM)2.40x

Pretax Margin (TTM)-257.85%

Book Value / Share (Annual)$16.26

Price vs S&P 500 (13W)-64.39%

Beta1.44x

Revenue / Share (TTM)$16.20

ROE (TTM)-269.24%

52-Week Low$2.40

vGradeB

gGradeA

mGradeF

vgmGradeC

TNON Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 13, 2026	-$8.40	-$12.35	-47.02%(-$3.95)
Q1 2026	May 12, 2026	-$10.68	-$10.85	-1.64%(-$0.17)
Q4 2025	Mar 19, 2026	-$12.60	-$7.70	+38.89%(+$4.90)
Q3 2025	Nov 13, 2025	-$12.95	-$14.00	-8.11%(-$1.05)
Q2 2025	Aug 13, 2025	-$16.45	-$12.60	+23.40%(+$3.85)

TNON Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.13

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
TNONTenon Medical, Inc. Common Stock	B	A	F	1.4x	150.5%	66.8%	-242.7%	$2.70
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About Tenon Medical, Inc. Common Stock

Tenon Medical develops minimally invasive solutions for treating sacroiliac joint disorders, a significant source of lower back pain. The company's Catamaran System—a single titanium implant—serves three market opportunities: primary procedures, revision surgeries, and spine fusion adjuncts. Currently, revenue is generated through sales to a limited number of clinicians, with potential for expansion as clinical adoption grows.

TNON Next Earnings Report

Report dateNov 12, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate-$5.62

Revenue estimate$1.43M

Also reporting on Nov 12, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

TNON Insider Transactions

SellSep 10, 2026
HRT FINANCIAL L.P
Beneficial Owner of more than 10% of a Class of Security
Shares: 125,925Value: $520,440
BuySep 10, 2026
HRT FINANCIAL L.P
Beneficial Owner of more than 10% of a Class of Security
Shares: 108,140Value: $455,560
SellSep 4, 2026
HRT FINANCIAL L.P
Beneficial Owner of more than 10% of a Class of Security
Shares: 1,506Value: $5,572
BuySep 3, 2026
HRT FINANCIAL L.P
Beneficial Owner of more than 10% of a Class of Security
Shares: 1,658Value: $6,599
SellSep 2, 2026
HRT FINANCIAL L.P
Beneficial Owner of more than 10% of a Class of Security
Shares: 450Value: $2,038

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for September 2026

Companies in Related Industries

RGNTRegentis Biomaterials Ltd.Orthopedic & Prosthetic Devices
ASTCAstrotech Corporation (DE) Common StockLab Analytical Instruments
MSAIMultiSensor AI Holdings, Inc. Common StockOptical Instruments & Lenses
DETXLiberty Defense Holdings, Ltd. Common SharesDefense Systems & Equipment
NDRAENDRA Life Sciences Inc. Common StockElectromedical Equipment
LUCYInnovative Eyewear, Inc. Common StockOphthalmic Goods
CLGNCollPlant Biotechnologies Ltd Ordinary SharesOrthopedic & Prosthetic Devices
NIKINiki BioSolutions, Inc. Common StockMeasuring & Controlling Devices

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$2.40

High$50.40